Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propionic Acid SCHEMBL2160998 | 0.88 | FFAR3 (0.46) | — | |
| Oxygen SCHEMBL7534336 | 0.84 | ALDH1A1 (0.37) | ALDH1A1TSHR | |
| SCHEMBL28369272 | 0.84 | ALDH1A1 (0.37) | ALDH1A1TSHR | |
| SCHEMBL175428 | 0.84 | TSHR (0.41) | ALDH1A1TSHRTDP1 | |
| SCHEMBL15026 | 0.84 | — | — | |
| SCHEMBL4379385 | 0.84 | — | — | |
| SCHEMBL5907424 | 0.84 | TSHR (0.41) | ALDH1A1TSHRTDP1 | |
| Formic Acid SCHEMBL29143697 | 0.83 | — | — | |
| Formic Acid SCHEMBL29143701 | 0.83 | — | — | |
| SCHEMBL28432047 | 0.81 | ALDH1A1 (0.35) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12540252-B2 | Active energy ray-curable inkjet ink, and printed matter | ARTIENCE CO., LTD. (JP) | 2026-02-03 | — | — | US | disclosed |
| EP-4442775-A1 | ACTIVE ENERGY RAY-CURABLE INK JET INK AND PRINTED MATTER | artience Co., Ltd. (JP) | 2024-10-09 | — | — | EP | disclosed |
| US-20240166902-A1 | ACTIVE ENERGY RAY-CURABLE INKJET INK, AND PRINTED MATTER | TOYO INK SC HOLDINGS CO., LTD. (JP) | 2024-05-23 | — | — | US | disclosed |
| US-11912905-B2 | Adhesive tape, method for immobilizing electronic device component or on-vehicle device component, method for manufacturing electronic device or on-vehicle device | SEKISUI CHEMICAL CO., LTD. (JP) | 2024-02-27 | — | — | US | disclosed |
| WO-2023188628-A1 | ACTIVE ENERGY RAY-CURABLE INK COMPOSITION FOR REVERSE PRINTING | サカタインクス株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023188625-A1 | ACTIVE ENERGY RAY-CURABLE ADHESIVE COMPOSITION | サカタインクス株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023188627-A1 | ACTIVE ENERGY RAY-CURABLE ADHESIVE COMPOSITION | サカタインクス株式会社 | 2023-10-05 | — | — | WO | disclosed |
| US-20230212441-A1 | ADHESIVE TAPE, METHOD FOR IMMOBILIZING ELECTRONIC DEVICE COMPONENT OR ON-VEHICLE DEVICE COMPONENT, METHOD FOR MANUFACTURING ELECTRONIC DEVICE OR ON-VEHICLE DEVICE | SEKISUI CHEMICAL CO., LTD. (JP) | 2023-07-06 | — | — | US | disclosed |
| EP-4174148-A1 | ADHESIVE TAPE, METHOD FOR IMMOBILIZING ELECTRONIC DEVICE COMPONENT OR ON-VEHICLE DEVICE COMPONENT, METHOD FOR MANUFACTURING ELECTRONIC DEVICE OR ON-VEHICLE DEVICE | SEKISUI CHEMICAL CO., LTD. (JP) | 2023-05-03 | — | — | EP | disclosed |
| EP-4174147-A1 | ADHESIVE TAPE, METHOD FOR FIXING ELECTRONIC DEVICE COMPONENT OR ON-BOARD DEVICE COMPONENT, AND METHOD FOR PRODUCING ELECTRONIC DEVICE OR ON-BOARD DEVICE | SEKISUI CHEMICAL CO., LTD. (JP) | 2023-05-03 | — | — | EP | disclosed |
| US-7985502-B2 | Containing formic ester additive; cycling properties, electrical capacity, storage during charging | UBE INDUSTRIES, LTD. (JP) | 2011-07-26 | — | — | US | disclosed |
| EP-1729365-B1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY USING THE SAME | UBE INDUSTRIES (JP) | 2010-12-22 | — | — | EP | disclosed |
| US-20080241704-A1 | Nonaqueous Electrolyte Solution and Lithium Secondary Battery Using Same | UBE INDUSTRIES, LTD (JP) | 2008-10-02 | — | — | US | disclosed |
| US-20070197837-A1 | Method for the hydrodecomposition of ammonium formates in polyolcontaining reaction mixtures | BASF AKTIENGESELLSCHAFT | 2007-08-23 | — | — | US | disclosed |
| CN-1934743-A | Nonaqueous electrolyte solution and lithium secondary battery using same | UBE INDUSTRIES (JP) | 2007-03-21 | — | — | CN | disclosed |
| EP-1729365-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY USING SAME | Ube Industries, Ltd. (JP) | 2006-12-06 | — | — | EP | disclosed |
| US-6914164-B2 | Method for the decomposition of ammonium formates in reaction mixtures containing polyol | BASF AG (DE) | 2005-07-05 | — | — | US | disclosed |
| US-20040254408-A1 | Method for the decomposition of ammonium formates in reaction mixtures containing polyol | BASF AKTIENGESELLSCHAFT (DE) | 2004-12-16 | — | — | US | disclosed |
| US-6692616-B2 | Method for purifying trimethylolpropane, which is produced by hydrogenation, by means of continuous distillation | BASF AKTIENGESELLSCHAFT (DE) | 2004-02-17 | — | — | US | disclosed |
| US-20020189926-A1 | Method for purifying trimethylolpropane, which is produced by hydrogenation, by means of continuous distillation | BASF AKTIENGESELLSCHAFT (DE) | 2002-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040254408-A1 | Method for the decomposition of ammonium formates in reaction mixtures containing polyol | MED1, ELL, AFF4 | ALDH1A1 476/4885TSHR 3525/4885MAPK1 2191/4885 |
| US-12540252-B2 | Active energy ray-curable inkjet ink, and printed matter | ACP1, MARK1, ACVRL1 | ALDH1A1 421/4885TSHR 4369/4885MAPK1 68/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.